カテゴリー： 世界, 医療/バイオ, LP Information

世界の創傷手術用止血剤市場予測 2023年-2029年

【英語タイトル】Global Wound Surgery Hemostatic Agents Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY3927）・商品コード：LP23MY3927
・発行会社（調査会社）：LP Information
・発行日：2023年5月（※2025年版があります。お問い合わせください。）
・ページ数：109
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の創傷手術用止血剤市場」は、過去の販売実績から2022年の世界の創傷手術用止血剤の総販売量を検討し、2023年から2029年の予測される創傷手術用止血剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の創傷手術用止血剤の市場規模を掲載し、XXX百万米ドル規模の世界の創傷手術用止血剤市場の詳細な分析を提供します。本インサイトレポートは、世界の創傷手術用止血剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の創傷手術用止血剤市場における各社の独自のポジションをより深く理解するために、創傷手術用止血剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の創傷手術用止血剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。創傷手術用止血剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。創傷手術用止血剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。創傷手術用止血剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

創傷手術用止血剤の世界主要メーカーとしては、B. Braun、 ENDOVISION、 BioCer Entwicklungs、 Ethicon、 Merit Medical Systems、 RevMedx、 Bioteck、 Anscare、 MEDGYN PRODUCTS、 HONG KONG MEDIなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の創傷手術用止血剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では創傷手術用止血剤市場をセグメンテーションし、種類別 (止血パッド、止血パウダー、止血ジェル、その他)、用途別 (病院、クリニック、ケアセンター、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：止血パッド、止血パウダー、止血ジェル、その他

・用途別区分：病院、クリニック、ケアセンター、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の創傷手術用止血剤市場の10年間の市場状況・展望は？
・世界および地域別に見た創傷手術用止血剤市場成長の要因は何か？
・創傷手術用止血剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・創傷手術用止血剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：創傷手術用止血剤の年間販売量2018-2029、地域別現状・将来分析
・創傷手術用止血剤の種類別セグメント：止血パッド、止血パウダー、止血ジェル、その他
・創傷手術用止血剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・創傷手術用止血剤の用途別セグメント：病院、クリニック、ケアセンター、その他
・創傷手術用止血剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の創傷手術用止血剤市場
・企業別のグローバル創傷手術用止血剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別の創傷手術用止血剤の年間売上：2018-2023年の売上、市場シェア
・企業別の創傷手術用止血剤販売価格
・主要企業の創傷手術用止血剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

創傷手術用止血剤の地域別レビュー
・地域別の創傷手術用止血剤市場規模2018-2023：年間販売量、売上
・主要国別の創傷手術用止血剤市場規模2018-2023：年間販売量、売上
・南北アメリカの創傷手術用止血剤販売の成長
・アジア太平洋の創傷手術用止血剤販売の成長
・ヨーロッパの創傷手術用止血剤販売の成長
・中東・アフリカの創傷手術用止血剤販売の成長

南北アメリカ市場
・南北アメリカの国別の創傷手術用止血剤販売量、売上（2018-2023）
・南北アメリカの創傷手術用止血剤の種類別販売量
・南北アメリカの創傷手術用止血剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の創傷手術用止血剤販売量、売上（2018-2023）
・アジア太平洋の創傷手術用止血剤の種類別販売量
・アジア太平洋の創傷手術用止血剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の創傷手術用止血剤販売量、売上（2018-2023）
・ヨーロッパの創傷手術用止血剤の種類別販売量
・ヨーロッパの創傷手術用止血剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の創傷手術用止血剤販売量、売上（2018-2023）
・中東・アフリカの創傷手術用止血剤の種類別販売量
・中東・アフリカの創傷手術用止血剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・創傷手術用止血剤の製造コスト構造分析
・創傷手術用止血剤の製造プロセス分析
・創傷手術用止血剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・創傷手術用止血剤の主要なグローバル販売業者
・創傷手術用止血剤の主要なグローバル顧客

地域別の創傷手術用止血剤市場予測レビュー
・地域別の創傷手術用止血剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・創傷手術用止血剤の種類別市場規模予測
・創傷手術用止血剤の用途別市場規模予測

主要企業分析
B. Braun、 ENDOVISION、 BioCer Entwicklungs、 Ethicon、 Merit Medical Systems、 RevMedx、 Bioteck、 Anscare、 MEDGYN PRODUCTS、 HONG KONG MEDI
・企業情報
・創傷手術用止血剤製品
・創傷手術用止血剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Wound Surgery Hemostatic Agents improve hemostasis by improving the initial hemostatic process, stimulating fibrin formation, or inhibiting fibrinolysis.
LPI (LP Information)’ newest research report, the “Wound Surgery Hemostatic Agents Industry Forecast” looks at past sales and reviews total world Wound Surgery Hemostatic Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected Wound Surgery Hemostatic Agents sales for 2023 through 2029. With Wound Surgery Hemostatic Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Wound Surgery Hemostatic Agents industry.
This Insight Report provides a comprehensive analysis of the global Wound Surgery Hemostatic Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Wound Surgery Hemostatic Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Wound Surgery Hemostatic Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Wound Surgery Hemostatic Agents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Wound Surgery Hemostatic Agents.
The global Wound Surgery Hemostatic Agents market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Wound Surgery Hemostatic Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Wound Surgery Hemostatic Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Wound Surgery Hemostatic Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Wound Surgery Hemostatic Agents players cover B. Braun, ENDOVISION, BioCer Entwicklungs, Ethicon, Merit Medical Systems, RevMedx, Bioteck, Anscare and MEDGYN PRODUCTS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Wound Surgery Hemostatic Agents market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Hemostatic Pad
Hemostatic Powder
Hemostatic Gel
Others
Segmentation by application
Hospital
Clinic
Care Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
B. Braun
ENDOVISION
BioCer Entwicklungs
Ethicon
Merit Medical Systems
RevMedx
Bioteck
Anscare
MEDGYN PRODUCTS
HONG KONG MEDI
Key Questions Addressed in this Report
What is the 10-year outlook for the global Wound Surgery Hemostatic Agents market?
What factors are driving Wound Surgery Hemostatic Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Wound Surgery Hemostatic Agents market opportunities vary by end market size?
How does Wound Surgery Hemostatic Agents break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Wound Surgery Hemostatic Agents Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Wound Surgery Hemostatic Agents by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Wound Surgery Hemostatic Agents by Country/Region, 2018, 2022 & 2029
2.2 Wound Surgery Hemostatic Agents Segment by Type
2.2.1 Hemostatic Pad
2.2.2 Hemostatic Powder
2.2.3 Hemostatic Gel
2.2.4 Others
2.3 Wound Surgery Hemostatic Agents Sales by Type
2.3.1 Global Wound Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
2.3.2 Global Wound Surgery Hemostatic Agents Revenue and Market Share by Type (2018-2023)
2.3.3 Global Wound Surgery Hemostatic Agents Sale Price by Type (2018-2023)
2.4 Wound Surgery Hemostatic Agents Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Care Center
2.4.4 Others
2.5 Wound Surgery Hemostatic Agents Sales by Application
2.5.1 Global Wound Surgery Hemostatic Agents Sale Market Share by Application (2018-2023)
2.5.2 Global Wound Surgery Hemostatic Agents Revenue and Market Share by Application (2018-2023)
2.5.3 Global Wound Surgery Hemostatic Agents Sale Price by Application (2018-2023)
3 Global Wound Surgery Hemostatic Agents by Company
3.1 Global Wound Surgery Hemostatic Agents Breakdown Data by Company
3.1.1 Global Wound Surgery Hemostatic Agents Annual Sales by Company (2018-2023)
3.1.2 Global Wound Surgery Hemostatic Agents Sales Market Share by Company (2018-2023)
3.2 Global Wound Surgery Hemostatic Agents Annual Revenue by Company (2018-2023)
3.2.1 Global Wound Surgery Hemostatic Agents Revenue by Company (2018-2023)
3.2.2 Global Wound Surgery Hemostatic Agents Revenue Market Share by Company (2018-2023)
3.3 Global Wound Surgery Hemostatic Agents Sale Price by Company
3.4 Key Manufacturers Wound Surgery Hemostatic Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Wound Surgery Hemostatic Agents Product Location Distribution
3.4.2 Players Wound Surgery Hemostatic Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Wound Surgery Hemostatic Agents by Geographic Region
4.1 World Historic Wound Surgery Hemostatic Agents Market Size by Geographic Region (2018-2023)
4.1.1 Global Wound Surgery Hemostatic Agents Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Wound Surgery Hemostatic Agents Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Wound Surgery Hemostatic Agents Market Size by Country/Region (2018-2023)
4.2.1 Global Wound Surgery Hemostatic Agents Annual Sales by Country/Region (2018-2023)
4.2.2 Global Wound Surgery Hemostatic Agents Annual Revenue by Country/Region (2018-2023)
4.3 Americas Wound Surgery Hemostatic Agents Sales Growth
4.4 APAC Wound Surgery Hemostatic Agents Sales Growth
4.5 Europe Wound Surgery Hemostatic Agents Sales Growth
4.6 Middle East & Africa Wound Surgery Hemostatic Agents Sales Growth
5 Americas
5.1 Americas Wound Surgery Hemostatic Agents Sales by Country
5.1.1 Americas Wound Surgery Hemostatic Agents Sales by Country (2018-2023)
5.1.2 Americas Wound Surgery Hemostatic Agents Revenue by Country (2018-2023)
5.2 Americas Wound Surgery Hemostatic Agents Sales by Type
5.3 Americas Wound Surgery Hemostatic Agents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Wound Surgery Hemostatic Agents Sales by Region
6.1.1 APAC Wound Surgery Hemostatic Agents Sales by Region (2018-2023)
6.1.2 APAC Wound Surgery Hemostatic Agents Revenue by Region (2018-2023)
6.2 APAC Wound Surgery Hemostatic Agents Sales by Type
6.3 APAC Wound Surgery Hemostatic Agents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Wound Surgery Hemostatic Agents by Country
7.1.1 Europe Wound Surgery Hemostatic Agents Sales by Country (2018-2023)
7.1.2 Europe Wound Surgery Hemostatic Agents Revenue by Country (2018-2023)
7.2 Europe Wound Surgery Hemostatic Agents Sales by Type
7.3 Europe Wound Surgery Hemostatic Agents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Wound Surgery Hemostatic Agents by Country
8.1.1 Middle East & Africa Wound Surgery Hemostatic Agents Sales by Country (2018-2023)
8.1.2 Middle East & Africa Wound Surgery Hemostatic Agents Revenue by Country (2018-2023)
8.2 Middle East & Africa Wound Surgery Hemostatic Agents Sales by Type
8.3 Middle East & Africa Wound Surgery Hemostatic Agents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Wound Surgery Hemostatic Agents
10.3 Manufacturing Process Analysis of Wound Surgery Hemostatic Agents
10.4 Industry Chain Structure of Wound Surgery Hemostatic Agents
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Wound Surgery Hemostatic Agents Distributors
11.3 Wound Surgery Hemostatic Agents Customer
12 World Forecast Review for Wound Surgery Hemostatic Agents by Geographic Region
12.1 Global Wound Surgery Hemostatic Agents Market Size Forecast by Region
12.1.1 Global Wound Surgery Hemostatic Agents Forecast by Region (2024-2029)
12.1.2 Global Wound Surgery Hemostatic Agents Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Wound Surgery Hemostatic Agents Forecast by Type
12.7 Global Wound Surgery Hemostatic Agents Forecast by Application
13 Key Players Analysis
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.1.3 B. Braun Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 ENDOVISION
13.2.1 ENDOVISION Company Information
13.2.2 ENDOVISION Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.2.3 ENDOVISION Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 ENDOVISION Main Business Overview
13.2.5 ENDOVISION Latest Developments
13.3 BioCer Entwicklungs
13.3.1 BioCer Entwicklungs Company Information
13.3.2 BioCer Entwicklungs Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.3.3 BioCer Entwicklungs Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BioCer Entwicklungs Main Business Overview
13.3.5 BioCer Entwicklungs Latest Developments
13.4 Ethicon
13.4.1 Ethicon Company Information
13.4.2 Ethicon Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.4.3 Ethicon Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ethicon Main Business Overview
13.4.5 Ethicon Latest Developments
13.5 Merit Medical Systems
13.5.1 Merit Medical Systems Company Information
13.5.2 Merit Medical Systems Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.5.3 Merit Medical Systems Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merit Medical Systems Main Business Overview
13.5.5 Merit Medical Systems Latest Developments
13.6 RevMedx
13.6.1 RevMedx Company Information
13.6.2 RevMedx Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.6.3 RevMedx Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 RevMedx Main Business Overview
13.6.5 RevMedx Latest Developments
13.7 Bioteck
13.7.1 Bioteck Company Information
13.7.2 Bioteck Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.7.3 Bioteck Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bioteck Main Business Overview
13.7.5 Bioteck Latest Developments
13.8 Anscare
13.8.1 Anscare Company Information
13.8.2 Anscare Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.8.3 Anscare Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Anscare Main Business Overview
13.8.5 Anscare Latest Developments
13.9 MEDGYN PRODUCTS
13.9.1 MEDGYN PRODUCTS Company Information
13.9.2 MEDGYN PRODUCTS Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.9.3 MEDGYN PRODUCTS Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 MEDGYN PRODUCTS Main Business Overview
13.9.5 MEDGYN PRODUCTS Latest Developments
13.10 HONG KONG MEDI
13.10.1 HONG KONG MEDI Company Information
13.10.2 HONG KONG MEDI Wound Surgery Hemostatic Agents Product Portfolios and Specifications
13.10.3 HONG KONG MEDI Wound Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 HONG KONG MEDI Main Business Overview
13.10.5 HONG KONG MEDI Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Wound Surgery Hemostatic Agents Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Wound Surgery Hemostatic Agents Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hemostatic Pad
Table 4. Major Players of Hemostatic Powder
Table 5. Major Players of Hemostatic Gel
Table 6. Major Players of Others
Table 7. Global Wound Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 8. Global Wound Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Table 9. Global Wound Surgery Hemostatic Agents Revenue by Type (2018-2023) & ($ million)
Table 10. Global Wound Surgery Hemostatic Agents Revenue Market Share by Type (2018-2023)
Table 11. Global Wound Surgery Hemostatic Agents Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Wound Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 13. Global Wound Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Table 14. Global Wound Surgery Hemostatic Agents Revenue by Application (2018-2023)
Table 15. Global Wound Surgery Hemostatic Agents Revenue Market Share by Application (2018-2023)
Table 16. Global Wound Surgery Hemostatic Agents Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Wound Surgery Hemostatic Agents Sales by Company (2018-2023) & (K Units)
Table 18. Global Wound Surgery Hemostatic Agents Sales Market Share by Company (2018-2023)
Table 19. Global Wound Surgery Hemostatic Agents Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Wound Surgery Hemostatic Agents Revenue Market Share by Company (2018-2023)
Table 21. Global Wound Surgery Hemostatic Agents Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Wound Surgery Hemostatic Agents Producing Area Distribution and Sales Area
Table 23. Players Wound Surgery Hemostatic Agents Products Offered
Table 24. Wound Surgery Hemostatic Agents Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Wound Surgery Hemostatic Agents Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Wound Surgery Hemostatic Agents Sales Market Share Geographic Region (2018-2023)
Table 29. Global Wound Surgery Hemostatic Agents Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Wound Surgery Hemostatic Agents Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Wound Surgery Hemostatic Agents Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Wound Surgery Hemostatic Agents Sales Market Share by Country/Region (2018-2023)
Table 33. Global Wound Surgery Hemostatic Agents Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Wound Surgery Hemostatic Agents Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Wound Surgery Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 36. Americas Wound Surgery Hemostatic Agents Sales Market Share by Country (2018-2023)
Table 37. Americas Wound Surgery Hemostatic Agents Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Wound Surgery Hemostatic Agents Revenue Market Share by Country (2018-2023)
Table 39. Americas Wound Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 40. Americas Wound Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 41. APAC Wound Surgery Hemostatic Agents Sales by Region (2018-2023) & (K Units)
Table 42. APAC Wound Surgery Hemostatic Agents Sales Market Share by Region (2018-2023)
Table 43. APAC Wound Surgery Hemostatic Agents Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Wound Surgery Hemostatic Agents Revenue Market Share by Region (2018-2023)
Table 45. APAC Wound Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 46. APAC Wound Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 47. Europe Wound Surgery Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 48. Europe Wound Surgery Hemostatic Agents Sales Market Share by Country (2018-2023)
Table 49. Europe Wound Surgery Hemostatic Agents Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Wound Surgery Hemostatic Agents Revenue Market Share by Country (2018-2023)
Table 51. Europe Wound Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 52. Europe Wound Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Wound Surgery Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Wound Surgery Hemostatic Agents Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Wound Surgery Hemostatic Agents Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Wound Surgery Hemostatic Agents Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Wound Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Wound Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Wound Surgery Hemostatic Agents
Table 60. Key Market Challenges & Risks of Wound Surgery Hemostatic Agents
Table 61. Key Industry Trends of Wound Surgery Hemostatic Agents
Table 62. Wound Surgery Hemostatic Agents Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Wound Surgery Hemostatic Agents Distributors List
Table 65. Wound Surgery Hemostatic Agents Customer List
Table 66. Global Wound Surgery Hemostatic Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Wound Surgery Hemostatic Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Wound Surgery Hemostatic Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Wound Surgery Hemostatic Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Wound Surgery Hemostatic Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Wound Surgery Hemostatic Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Wound Surgery Hemostatic Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Wound Surgery Hemostatic Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Wound Surgery Hemostatic Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Wound Surgery Hemostatic Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Wound Surgery Hemostatic Agents Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Wound Surgery Hemostatic Agents Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Wound Surgery Hemostatic Agents Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Wound Surgery Hemostatic Agents Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. B. Braun Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 81. B. Braun Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 82. B. Braun Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. B. Braun Main Business
Table 84. B. Braun Latest Developments
Table 85. ENDOVISION Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 86. ENDOVISION Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 87. ENDOVISION Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. ENDOVISION Main Business
Table 89. ENDOVISION Latest Developments
Table 90. BioCer Entwicklungs Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 91. BioCer Entwicklungs Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 92. BioCer Entwicklungs Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. BioCer Entwicklungs Main Business
Table 94. BioCer Entwicklungs Latest Developments
Table 95. Ethicon Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 96. Ethicon Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 97. Ethicon Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Ethicon Main Business
Table 99. Ethicon Latest Developments
Table 100. Merit Medical Systems Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 101. Merit Medical Systems Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 102. Merit Medical Systems Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Merit Medical Systems Main Business
Table 104. Merit Medical Systems Latest Developments
Table 105. RevMedx Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 106. RevMedx Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 107. RevMedx Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. RevMedx Main Business
Table 109. RevMedx Latest Developments
Table 110. Bioteck Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 111. Bioteck Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 112. Bioteck Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Bioteck Main Business
Table 114. Bioteck Latest Developments
Table 115. Anscare Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 116. Anscare Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 117. Anscare Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Anscare Main Business
Table 119. Anscare Latest Developments
Table 120. MEDGYN PRODUCTS Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 121. MEDGYN PRODUCTS Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 122. MEDGYN PRODUCTS Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. MEDGYN PRODUCTS Main Business
Table 124. MEDGYN PRODUCTS Latest Developments
Table 125. HONG KONG MEDI Basic Information, Wound Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 126. HONG KONG MEDI Wound Surgery Hemostatic Agents Product Portfolios and Specifications
Table 127. HONG KONG MEDI Wound Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. HONG KONG MEDI Main Business
Table 129. HONG KONG MEDI Latest Developments
List of Figures
Figure 1. Picture of Wound Surgery Hemostatic Agents
Figure 2. Wound Surgery Hemostatic Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Wound Surgery Hemostatic Agents Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Wound Surgery Hemostatic Agents Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Wound Surgery Hemostatic Agents Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hemostatic Pad
Figure 10. Product Picture of Hemostatic Powder
Figure 11. Product Picture of Hemostatic Gel
Figure 12. Product Picture of Others
Figure 13. Global Wound Surgery Hemostatic Agents Sales Market Share by Type in 2022
Figure 14. Global Wound Surgery Hemostatic Agents Revenue Market Share by Type (2018-2023)
Figure 15. Wound Surgery Hemostatic Agents Consumed in Hospital
Figure 16. Global Wound Surgery Hemostatic Agents Market: Hospital (2018-2023) & (K Units)
Figure 17. Wound Surgery Hemostatic Agents Consumed in Clinic
Figure 18. Global Wound Surgery Hemostatic Agents Market: Clinic (2018-2023) & (K Units)
Figure 19. Wound Surgery Hemostatic Agents Consumed in Care Center
Figure 20. Global Wound Surgery Hemostatic Agents Market: Care Center (2018-2023) & (K Units)
Figure 21. Wound Surgery Hemostatic Agents Consumed in Others
Figure 22. Global Wound Surgery Hemostatic Agents Market: Others (2018-2023) & (K Units)
Figure 23. Global Wound Surgery Hemostatic Agents Sales Market Share by Application (2022)
Figure 24. Global Wound Surgery Hemostatic Agents Revenue Market Share by Application in 2022
Figure 25. Wound Surgery Hemostatic Agents Sales Market by Company in 2022 (K Units)
Figure 26. Global Wound Surgery Hemostatic Agents Sales Market Share by Company in 2022
Figure 27. Wound Surgery Hemostatic Agents Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Wound Surgery Hemostatic Agents Revenue Market Share by Company in 2022
Figure 29. Global Wound Surgery Hemostatic Agents Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Wound Surgery Hemostatic Agents Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Wound Surgery Hemostatic Agents Sales 2018-2023 (K Units)
Figure 32. Americas Wound Surgery Hemostatic Agents Revenue 2018-2023 ($ Millions)
Figure 33. APAC Wound Surgery Hemostatic Agents Sales 2018-2023 (K Units)
Figure 34. APAC Wound Surgery Hemostatic Agents Revenue 2018-2023 ($ Millions)
Figure 35. Europe Wound Surgery Hemostatic Agents Sales 2018-2023 (K Units)
Figure 36. Europe Wound Surgery Hemostatic Agents Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Wound Surgery Hemostatic Agents Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Wound Surgery Hemostatic Agents Revenue 2018-2023 ($ Millions)
Figure 39. Americas Wound Surgery Hemostatic Agents Sales Market Share by Country in 2022
Figure 40. Americas Wound Surgery Hemostatic Agents Revenue Market Share by Country in 2022
Figure 41. Americas Wound Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Figure 42. Americas Wound Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Figure 43. United States Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Wound Surgery Hemostatic Agents Sales Market Share by Region in 2022
Figure 48. APAC Wound Surgery Hemostatic Agents Revenue Market Share by Regions in 2022
Figure 49. APAC Wound Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Figure 50. APAC Wound Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Figure 51. China Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Wound Surgery Hemostatic Agents Sales Market Share by Country in 2022
Figure 59. Europe Wound Surgery Hemostatic Agents Revenue Market Share by Country in 2022
Figure 60. Europe Wound Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Figure 61. Europe Wound Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Figure 62. Germany Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Wound Surgery Hemostatic Agents Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Wound Surgery Hemostatic Agents Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Wound Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Wound Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Figure 71. Egypt Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Wound Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Wound Surgery Hemostatic Agents in 2022
Figure 77. Manufacturing Process Analysis of Wound Surgery Hemostatic Agents
Figure 78. Industry Chain Structure of Wound Surgery Hemostatic Agents
Figure 79. Channels of Distribution
Figure 80. Global Wound Surgery Hemostatic Agents Sales Market Forecast by Region (2024-2029)
Figure 81. Global Wound Surgery Hemostatic Agents Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Wound Surgery Hemostatic Agents Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Wound Surgery Hemostatic Agents Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Wound Surgery Hemostatic Agents Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Wound Surgery Hemostatic Agents Revenue Market Share Forecast by Application (2024-2029)

※参考情報

創傷手術用止血剤は、外科手術や外傷において出血を制御するために使用される薬剤や材料を指します。出血は手術中や外傷時にしばしば見られる重大な合併症であり、適切に管理されないと患者の病状を悪化させ、回復を妨げることがあります。そのため、創傷手術用止血剤は医療現場で非常に重要な役割を果たしています。

創傷手術用止血剤の定義としては、主に血液凝固を促進し、出血を抑制するために用いられる物質や製品と定義できます。これらは、外科手術の際に使用される場合もあれば、外的な衝撃や傷による突然の出血を止めるためにも使用されます。止血剤は、傷口を閉じるための物理的な補強や、血液凝固を促進するための生理的または化学的メカニズムを利用して働きます。

このような止血剤の特徴には、迅速な効果、使用の容易さ、患者への安全性などが挙げられます。迅速な効果とは、出血を止めるまでの時間が短いことを意味し、特に緊急の治療が求められる状況では非常に重要です。また、使用の容易さは、医療従事者が迅速に使用できることが求められ、特に手術中の時間的制約の中で、その特性は大きな価値を持ちます。さらに患者への安全性に関しては、アレルギー反応や副作用のリスクが低いことが望まれます。

創傷手術用止血剤の種類には、様々なタイプがあります。まずは、物理的な止血剤です。これには、ガーゼ、包帯、膠着剤（フィブリンなど）などが含まれ、物理的に傷口を覆うことで出血を抑える役割を果たします。次に、化学的な止血剤があります。これは、血液凝固を促す薬剤であり、トロンビンやコラゲナーゼなどの酵素を含むものがあります。これらの化学成分が血液の凝固プロセスを促進し、出血を止める効果を持ちます。

さらに、最近の技術進歩によって開発されたバイオマテリアル系の止血剤も注目されています。たとえば、植物由来のポリマーや、合成ポリマーを用いた止血剤は、生体適合性が高く、使用後の副作用が少ないことが特徴です。こうしたバイオマテリアルは、傷の治癒を促進するだけでなく、感染リスクを低減するのにも寄与します。

創傷手術用止血剤の用途は広範囲に及びます。外科手術、外傷処置、整形外科手術、脳神経外科手術、心臓手術など、多くの専門領域で使用されており、手術中の出血を効果的に管理するために不可欠です。一方、緊急医療や救急処置においても、創傷止血剤は重要な役割を果たします。特に、外傷事故や戦場での出血に対して迅速な応急処置を行うために、簡便で効果的な止血剤の需要が高まっています。

加えて、創傷手術用止血剤に関連する技術も進化しています。たとえば、ナノテクノロジーを利用した止血剤は、微細な粒子を使用して出血部位での血液の凝固を効果的に促進することが期待されています。また、レーザー技術を用いた止血方法も開発されており、血管を直接焼灼することで出血を止めることができるため、侵襲性が少なく、術後の回復が早いという利点があります。

さらに、創傷手術用止血剤は、今後の研究や技術開発によってますます多様化し、不明な出血原因の解明や、個々の患者に合った止血剤の選定、そしてより安全で効果的な治療法の確立が期待されています。

総じて、創傷手術用止血剤は、外科手術や外傷において出血を効果的に管理するために重要であり、その種類や用途も多岐にわたります。医療現場では、これらの止血剤の特性を理解し、適切に選択・使用することが、患者の安全と治療効果を高める鍵となるでしょう。これからも止血剤に関する研究や技術開発が進むことで、より安全で効果的な治療が実現すると期待されています。


★調査レポート[世界の創傷手術用止血剤市場予測 2023年-2029年] (コード：LP23MY3927)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の創傷手術用止血剤市場予測 2023年-2029年]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆